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ABSTRACT
Background. Salvia officinalis (sage) is a native plant to the Mediterranean region
and has been used for a long time in traditional medicine for various diseases. We
investigated possible anti-diabetic, anti-inflammatory and anti-obesity effects of sage
methanol (MetOH) extract in a nutritional mouse model of obesity, inflammation and
insulin resistance, as well as its effects on lipolysis and lipogenesis in 3T3-L1 cells.
Methods. Diet-induced obese (DIO) mice were treated for five weeks with sage
methanol extract (100 and 400 mg kg−1/day bid), or rosiglitazone (3 mg kg−1/day bid),
as a positive control. Energy expenditure, food intake, body weight, fat mass, liver
glycogen and lipid content were evaluated. Blood glucose, and plasma levels of insulin,
lipids leptin and pro- and anti-inflammatory cytokines were measured throughout the
experiment. The effects of sage MetOH extract on lipolysis and lipogenesis were tested
in vitro in 3T3-L1 cells.
Results. After two weeks of treatment, the lower dose of sage MetOH extract decreased
blood glucose and plasma insulin levels during an oral glucose tolerance test (OGTT).
An insulin tolerance test (ITT), performed at day 29 confirmed that sage improved
insulin sensitivity. Groups treated with low dose sage and rosiglitazone showed
very similar effects on OGTT and ITT. Sage also improved HOMA-IR, triglycerides
and NEFA. Treatment with the low dose increased the plasma levels of the anti-
inflammatory cytokines IL-2, IL-4 and IL-10 and reduced the plasma level of the pro-
inflammatory cytokines IL-12, TNF-α, and KC/GRO. The GC analysis revealed the
presence of two PPARs agonist in sage MetOH extract. In vitro, the extract reduced in a
dose-related manner the accumulation of lipid droplets; however no effect on lipolysis
was observed.
Conclusions. Sage MetOH extract at low dose exhibits similar effects to rosiglitazone.
It improves insulin sensitivity, inhibits lipogenesis in adipocytes and reduces inflam-
mation as judged by plasma cytokines. Sage presents an alternative to pharmaceuticals
for the treatment of diabetes and associated inflammation.
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INTRODUCTION
In the recent decades, there has been renewed interest in traditional and alternativemedicine
and thousands of potential medicinal plants have been screened to identify bio-active lead
components. Salvia officinalis (Sage) has been extensively used as a medicinal plant in
treating several diseases and recent studies have shown promising activity in treating
cancer (Shahneh et al., 2013), heart disease, dementia and obesity (Hamidpour et al., 2014).
Studies have suggested that sage extracts enhance glycemic balance in normal and
diabetic animals. Alarcon-Aguilar et al. (2002) showed that a water ethanolic extract from
S. officinalis injected intraperitoneally had hypoglycemic effects in fasted normoglycemic
mice and in fasted alloxan-induced mildly diabetic mice. In addition, Eidi, Eidi &
Zamanizadeh (2005) showed that sage methanolic (MetOH) extract given intraperitoneally
reduced significantly serum glucose in fasted streptozotocin (STZ)-induced diabetic
rats without changes in plasma insulin levels. In another study, sage ethanolic extract
significantly decreased serum glucose, triglycerides and total cholesterol, whereas it
increased serum insulin levels in STZ-treated diabetic rats as compared with control
diabetic rats (Eidi & Eidi, 2009). Sage essential oil tested in normal and in alloxan-induced
diabetic rats improved glycemia (Baricevic & Bartol, 2000) and increased the response of the
hepatocytes to insulin in normal animals but not in hepatocytes isolated from STZ diabetic
rat (Lima et al., 2006). Sage is reported to elicit antidiabetic effects largely due to activation
of peroxisome proliferator-activated receptors (PPARs) (Christensen et al., 2010).
Most of the studies described above have investigated the anti-diabetic effects of sage
in alloxan- or streptozotocin-induced diabetic animals. However, the effects of sage on
insulin sensitivity and glucose tolerance in a nutritional animalmodel of obesity and insulin
resistance have not been described before. The aim of our present study is to assess the
potential anti-inflammatory, anti-obesity, and anti-diabetic effects of low and high doses
of a MetOH extract of S. officinalis leaves, in a high fat diet-induced obesity mice model,
which is a nutritional animal model of obesity associated with dyslipidemia, inflammation
and insulin resistance and to appraise the effect of sage MetOH extract in 3T3-L1 cells on
lipolysis and lipogenesis.
MATERIALS AND METHODS
Chemicals and reagents
Methanol (Sigma-Aldrich, Munich, Germany), dimethyl sulfoxide (DMSO, Biotech
grade, 99.98%; Sigma–Aldrich, Munich, Germany), Dulbecco’s modified Eagle’s medium
(DMEM), 0.25% trypsin-EDTA (1X), fetal bovine serum (FBS), streptomycin/penicillin
(Gibco BRL, Life Technologies, Carlsbad, CA, USA), bovine insulin (Sigma I-5500),
dexamethasone, (Sigma D-4902), 3–isobutyl–1 methylxanthine (IBMX; Sigma I-7018),
rosiglitazone maleate (SRP0135r; Sequoia RP, UK).
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Preparation of plant material
Leaves of Salvia officinalis (Lamiaceae Plant family) were collected from the open field
botanic garden of the Higher Institute of Agronomy, University of Sousse, Tunisia and
were identified by Pr. Rabiaa Hawéla at the cited institute. Voucher specimens were
deposited at the Faculty of Medicine of Monastir, Tunisia, and referenced as SO011.
Air dried leaves were submitted to extraction with 80% MetOH solution in a Soxhlet
apparatus for 24 h. The solvent was then filtered and evaporated by Rotavapor at 55 ◦C.
The recuperated aqueous portion was lyophilized and stored at −20 ◦C, for fatty acids
(FAs) analysis, and for in vitro and in vivo experiments.
Fatty acid methylation and analysis
Fatty acid (FA) extraction was performed using a modified method of Folch, Lees & Sloane
Stanley (1957). Heptadecanoic acid (C17:0) was used as an internal standard in order to
quantify FAs. Total FAs were converted into their methyl esters using MetOH/H2SO4 at
2.5%. FAmethyl esters (FAMEs) were analyzed using a Hewlett Packard 5890 IIGC (Agilent
Technologies, USA) equipped with Flame Ionization Detector (FID) and SupelcowaxTM 10
capillary column (30 m × 0.32 mm, i.d ., 0.25 µm film thickness) with a stationary
phase made of polyethylene glycol. FAMEs were identified by comparing each sample
with a standard FAME reference mixture. FA acid peak areas were calculated using HP
ChemStation software, quantified according to their percentage area and expressed in µg/g
of dry plant material.
HPLC Phenolic compounds analysis in sage methanol extract
HPLC analysis was carried out as reported by Mhamdi et al. (2009). Separation was
performed using aHewlett-Packard liquid chromatographic system (Waldbronn) equipped
with a Rheodyne Model 7125 injector (Rheodyne LP Cotati, CA, USA), a HP 1100 pump
system and an HP 1040M detector (diode array detection system, DAD). The column was
an XDB-C18 (250 mm × 4.6 mm I.D., 5 µm particle size). The mobile phase consisted of
acetonitrile/acidified water (solvent A) with 0.2% sulfuric acid (solvent B). The selected
gradient was as follows: 15% A/85% B, 0–12 min; 40% A/60% B, 12–14 min; 60% A/40%
B, 14–18 min; 80% A/20% B, 18–20 min; 90% A/10% B, 20–24 min; 100% A, 24–28 min
(Bourgou et al., 2008). The flow rate was maintained at 2 mL/min and a final volume of
20 µL was injected. The data were stored and processed by an HPLC Chemstation (Dos
Series; Hewlett-Packard, Palo Alto, CA, USA) and identification of compounds was carried
out by comparison of their retention time with respect to pure standards analyzed under
the same operating conditions.
In vitro experiment
Cell culture
3T3-L1 cell line was purchased from Sigma, UK (Ref: 86052701). After a few passages in
the growth medium containing basal Dulbecco’s Modified Eagle’s Medium—high glucose,
(DMEM) supplemented with fetal bovine serum (FBS) 10%, and Penicillin-Streptomycin
(S/P) 100 IU/ml, the cells were seeded in 24 well plates in the growth medium until
they reached confluency. To initiate pre-adipocytes differentiation into adipocyte-like
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cells, the cells were incubated in the differentiation medium (day 0) containing 10%
FBS supplemented DMEM with S/P, 5 µg/ml bovine insulin, 0.5 mM IBMX and 0.5 µM
dexamethasone. On day 3, the differentiation medium was replaced by the nutrition
medium (10% FBS supplemented DMEM with S/P and 5.10−3 mg/ml bovine insulin). By
day 7–10, mature adipocytes were obtained.
Glycerol release
After complete differentiation of pre-adipocytes, the nutrition media was removed and
mature 3T3-L1 cells were incubated for 90 min at 37 ◦C, in 0.5 ml of DMEM/ Ham’s
F-12[1:1], containing 0.1% of BSA and with or without 0.2, 1, 5, 25 and 50 µg/ml of sage
MetOH extract dissolved in 0.01% DMSO. The glycerol released into the medium was
quantified by using a colorimetric method (Glycerol kit, GY105; Randox, Crumlin, Dublin,
Ireland Randox). Optical density was measured at 520 nm using SpectraMax 96- well plate
reader.and results expressed in µmol/mg of cell protein.
Lipid droplets accumulation
To evaluate the effects of sage extract on lipid droplets accumulation, the cells were treated
with the plant extract dissolved in 0.01% DMSO at the following concentrations: 0, 0.2,
1, 5, 25 and 50 µg/ml. The extract was added to the differentiation medium, the nutrition
medium, or both media. Lipid droplets accumulation was assessed by staining lipids with
Oil red O as employed by Ramírez-Zacarías, Castro-Muñozledo & Kuri-Harcuch (1992).
The absorbance of the eluted dye was measured at 500 nm,
In vivo experiment
Animal model
32 male mice (C57Bl6) aged 6–7 weeks on arrival (Source: Harlan UK) were fed on a high
fat diet (60% fat by energy value; cat #D12492, Research Diets, US. Diet composition is
described in Table 1) for 9 weeks before treatment. Themice were housed at 25± 1 ◦C, 40%
to 60% air humidity and 12 h light/dark cycle in groups of four per cage with free access
to high fat diet (HFD) and tap water. Animal experiments were conducted in accordance
with ethical procedures and policies approved by the UK Government Animal Act 1986
(Scientific procedures) Project Licence (PPL 70/7189), entitled ‘‘Identifying diabetes,
obesity and metabolic diseases therapeutics’’, and Animal Welfare and Ethical Review
Board (AWERB) of the University of Buckingham, UK.
After 9 weeks of HFD feeding, mice were fasted for 5 h from 09:00 and fasting blood
glucose and plasma insulin were measured. 31 mice exhibited plasma insulin levels over
250 pmol l−1, one mouse was excluded because of normal plasma insulin level (less than
150 pmol l−1). Mice were then allocated into four groups with approximately the same
body weight, plasma insulin and blood glucose levels. Seven mice in group A, eight mice
in group B, eight mice in group C and eight mice in group D.
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Table 1 Composition of the Rodent Diet with 60% kcal%fat. The high fat diet was formulated by EA
Ulman, Ph.D. (Research Diets, Inc., New Brunswick, NJ, USA). The respective fat percentages in satu-
rated, monounsaturated and polyunsaturated fatty acids are 37.1%, 46% and 16.9%.
Product # High fat diet D12492
gm% kcal%
Protein 26.2 20
Carbohydrate 26.3 20
Fat 34.9 60
Total 100
kcal/gm 5.24
Ingredient gm kcal
Casein, 80 Mesh 200 800
L-Cysine 3 12
Corn Starch 0 0
Maltodextrin 10 125 500
Sucrose 63.8 275.2
Cellulose, BW200 50 0
Soybean Oil 25 225
Lard 245 2,205
Mineral Mix, S10026 10 0
DiCalcium Phosphate 13 0
Calcium Carbonate 5.5 0
Potassium Citrate, 1 H2O 16.5 0
Vitamin Mix, V10001 10 40
Choline Bitartrate 2 0
FD&C Blue Dye #1 0.05 0
Total 773.85 4,057
Animals were treated as described below for five weeks:
A: Control (water, 10 ml kg−1/day bid)
B: Sage extract (100 mg kg−1/day bid)
C: Sage extract (400 mg kg−1/day bid)
D: Rosiglitazone (3 mg kg−1/day bid)
The animals were dosed twice per day at 9:00 am and 5:00 pm.
Analysis
Biochemical analysis
Blood samples were centrifuged at 5,000 g for 6 min and plasma were collected into
96-well plates and stored at −20 ◦C until assayed. The tested biochemical parameters
were: insulin (Ultra Sensitive Mouse Insulin ELISA kit, Catalog #: 90080; Crystal Chem,
Downers Grove, IL, USA), leptin (Catalog #: 90030; Chrystal Chem), total cholesterol
(ref: CH200; Randox Laboratories), triglycerides (ref: TR1697; Randox Laboratories), high
density lipoprotein cholesterol (HDL-C) (ref: 354LB; Trinity Biotech, Bray, Co. Wicklow,
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Ireland). Blood glucose was measured using a glucose oxidase reagent kit (Gluc-PAP,
GL2623; Randox). All parameters were analyzed automatically using SpectraMax 250 and
SoftMax Pro software.
Body composition
Lean and fat mass were measured by Nuclear Magnetic Resonance (NMR), using the
minispec LF 90II device (Bruker UK Limited). The different types of tissue were identified
according to their density by comparison with a calibrated standard. Dedicated software is
used to quantify amounts of lean and fat.
Energy expenditure
After 35 days of treatment, energy expenditure was measured by indirect calorimetry as
reported by Stocker et al. (2007). Energy expenditure was evaluated based on the equation
of Weir using customized software (Arch et al., 2006).
Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
OGTT and ITT were performed respectively at two and four weeks following the start
of treatment with the plant extract. Mice were fasted for 5 h before the OGTT and ITT.
We and others routinely use a fast of about this length. Fasting mice for 5–6 h instead
of overnight might offer a better comparison to humans. Indeed, after having reviewed a
number of studies, Jensen et al. (2013) concluded that because the mouse has a nocturnal
circadian rhythm (two-thirds of total food intake are consumed during the night) and a
higher metabolic rate, therefore, a 16–18 h fast affects metabolism far more in mice than
in humans. Overnight fast is a routine event in humans, but not in mice.
For OGTT, 5 h-fasted mice received by oral gavage a glucose solution (in distilled water)
2.5 g/10 ml kg−1, and blood samples (10 µl) were collected by incision from the tail for
glucose measurement at 30 and 0min before, and, 30, 60, 120 and 180min after the glucose
load. Plasma insulin levels were measured at −30 and +30 min. Blood glucose levels were
measured using glucose oxidase reagent. For the ITT, 5 h-fasted mice received 0.75 IU/kg
of insulin solution (Actrapid. HM, Novo Nordisk, Denmark) by intraperitoneal injection,
and blood glucose was measured at just prior to the insulin injection, and at 10, 20, 30, 45,
and 60 min following the injection.
Liver Triglycerides measurement
About 150 to 300 mg of liver samples were used to assess triglycerides content as described
by Harzallah et al. (2016). The reading was performed using the Randox triglycerides kit.
Liver glycogen measurement
The glycogen content was determined according to Deng et al. (2016). The concentration
was expressed in mmol of glycosyl residues/g tissue.
Inflammatory cytokines measurement
The pro- and anti-inflammatory cytokines interleukin IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10,
IL-12p70, tumor necrosis factor-α (TNF-α), keratinocyte-derived chemoattractant/human
growth-regulated oncogene (KC/GRO) and interferon-γ (IFN-γ) were measured using
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Meso Scale multiplex assay kit (V-PLEX, Pro-inflammatory Panel 1 mouse kit, Ref:
K15048D-1; Meso Scale, Rockville, MD, USA). Optical density was read using an MSD
instrument (SECTOR Imager 2400), and the data were analyzed using Proprietary Meso
Scale software.
Statistical analysis
Statistical analysis was carried out by one way ANOVA followed by Dunnett’s Multiple
Comparison Test and Student t -test using GraphPad Prism software version 5.0. All
results are presented as means ± S.E.M. Statistical significance is indicated by ∗P < 0.05,
∗∗P < 0.01; ∗∗∗P < 0.001.
RESULTS
Glycerol release in 3T3-L1 cells
The lipolytic effect of sage in 3T3-L1 cells was determined by measuring glycerol release
(Fig. 1A). Compared to the untreated cells, no difference was observed in glycerol levels
measured in the medium of treated cells with the plant extract at 0.2, 1, 5, 25 or 50 µg/ml.
Lipid droplets accumulation
When the cells were treated with sage extract during the differentiation or the nutrition
step, (Figs. 1B and 1C) there was a significant reduction in the lipid accumulation only
in the cells treated with highest two concentrations (25 and 50 µg/ml). However, when
sage extract was added to both differentiation and nutrition media (Fig. 1D), there was an
inhibitory effect on lipid droplets accumulation even with the low sage concentration (0.2
and 1 µg/ml) with an overall concentration-dependant manner.
Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT)
OGTT was performed after 14 days of treatment. There was no change in fasted blood
glucose in all treated groups, but 30 min following the glucose load, the blood glucose levels
in mice treated with high (p< 0.05) and low (p< 0.001) dose of sage extract, and mice
treated with rosiglitazone (p< 0.001) were significantly lower, compared to the control
group values (Fig. 2A). Moreover, the low dose of sage extract exhibited a similar effect
to that of rosiglitazone on blood glucose, and tended to decrease fasting plasma insulin
levels (p= 0.08). Compared to the control mice, the plasma insulin levels measured 30
min in response to glucose load, were significantly lower in rosiglitazone treated group
(p< 0.001), and in low (p< 0.01) and high dose (p< 0.05) treated groups (Fig. 2B).
After 3 weeks, there was no difference in 5 h fasted blood glucose levels of sage or
rosiglitazone treated mice compared to control group (Fig. 3A). However, the treatment
with high and low dose sage, and rosiglitazone resulted in a significant reduction in fasted
plasma insulin levels (high dose sage: 698 ± 132 pmol l−1, p< 0.05; low dose sage: 491
± 50 pmol l−1, p< 0.01; rosiglitazone: 284 ± 36 pmol l−1, p< 0.001). Consequently, the
insulin sensitivity index, as represented by the Homeostasis Model Assessment of Insulin
Resistance (HOMA-IR) was respectively reduced by 39, 60 and 78%, indicating a marked
improvement in insulin sensitivity by both sage extract and rosiglitazone (Fig. 3B).
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Figure 1 Effects of Salvia officinalismethanol (sage MetOH) extract on lipolysis and lipogenesis in
3T3-L1 cells. Levels of glycerol released in the culture medium of fully differentiated adipocytes after be-
ing incubated for 90 min with or without 0.2, 1, 5, 25 and 50 µg/ml of methanol sage extract (A). Lipid
droplets accumulation measured in 3T3-L1 cells treated with different sage extract concentrations dur-
ing the stage of differentiation (B), nutrition (C), or both (D). All values are mean± SEM (n= 4, in each
treated cell group). Statistical analysis were performed using one way anova test followed by Dunnett’s
multiple comparison test. ∗p< 0.05; ∗∗∗p< 0.001.
Full-size DOI: 10.7717/peerj.4166/fig-1
An ITT was carried out after four weeks of treatment. The fasted blood glucose levels
were reduced in low dose sage and rosiglitazone groups compared to control (p< 0.05 and
p< 0.01, respectively) (Fig. 3C). Both groups showed a significant drop in blood glucose
levels 10 and 20 min following the insulin injection (Fig. 3C). Despite the lower blood
glucose levels in response to insulin injection in high dose sage treated group, no statistical
significance was observed. Nevertheless, the ITT supported evidence from the OGTT that
the sage extract improved insulin sensitivity.
Ben Khedher et al. (2018), PeerJ, DOI 10.7717/peerj.4166 8/22
Figure 2 Oral glucose tolerance test (A) and plasma insulin levels 30 min before and after glucose load
(B).HFD mice were treated for two weeks with sage MetOH extract (100 mg/kg/day and 400 mg/kg/day),
and rosiglitazone (3 mg/kg/day). Glucose solution (2.5 g/kg) was given orally after 5 h fast. Blood glucose
values represent mean+ SEM (n = 7 in group A and n = 8 in groups B, C and D), and statistical signifi-
cance compared with the vehicle group data is shown as: ∗P < 0.05, ∗∗P < 0.01 and ∗∗∗P < 0.001.
Full-size DOI: 10.7717/peerj.4166/fig-2
Effect of treatment on biochemical parameters
After 5 weeks of treatment, there was no change in fed plasma leptin, total cholesterol
and HDL-cholesterol levels (Figs. 4B–4D). On the other hand, the low dose of sage extract
significantly decreased fed plasma insulin, triglycerides and NEFA levels (Figs. 4A, 4E and
4F). There was no difference in liver triglycerides and glycogen contents between all groups.
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Figure 3 Effects of Salvia officinalis MetOH extract on fasted blood glucose, and insulin sensitivity.
Blood glucose levels were measured after a 5-hour fast (A), and insulin sensitivity is represented by the
product of blood glucose and plasma insulin values (B), after three weeks of treatment with sage MetOH
extract (100 mg/kg/day and 400 mg/kg/day), and rosiglitazone (3 mg/kg/day). Blood glucose levels were
observed during the Insulin tolerance test (C), performed at day 29 of treatment. Insulin (Actrapid,
0.75 UI/kg/ml in saline) was injected intraperitoneally to 5-hour fasted mice. All values are means± SEM
(n= 7 in group A and n= 8 in groups B, C and D). ∗P < 0.05, ∗∗P < 0.01 and ∗∗∗P < 0.001 as compared to
the vehicle-treated group.
Full-size DOI: 10.7717/peerj.4166/fig-3
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Figure 4 Plasma levels of insulin (A), leptin (B), total cholesterol (C), HDL-Cholesterol (D), Triglyc-
erides (E), and NEFA (F), after five weeks of treatment with sage MetOH extract. The plasma samples
were collected from fed mice, at the termination day, after five weeks treatment with sage MetOH extract
(100 mg/kg/day and 400 mg/kg/day), and rosiglitazone (3 mg/kg/day). Values represent mean± SEM
(n= 7 in group A and n= 8 in groups B, C and D), and statistical significance compared with the vehicle
group data is shown as: ∗P < 0.05 and ∗∗P < 0.01.
Full-size DOI: 10.7717/peerj.4166/fig-4
Table 2 Cumulative food intake, bodyweight change, lean and fat mass at day 32 of treatment. Lean and fat mass were measured by Nuclear
Magnetic Resonance (NMR).
Group A
Control
Group B
100mg kg−1
Group C
400mg kg−1
Group D
Rosiglitazone
Cumulative food intake (g) 73.5± 3.6 61.5± 2.4* 68.6± 2.3 64.7± 3.1
Cumulative bodyweight change (g) 4.51± 1.14 0.96± 0.73* 3.39± 0.89 1.95± 0.82
Lean mass (g) 24.6± 2.2 23.3± 1.4 25.5± 2.0 24.0± 1.6
Fat mass (g) 19.0± 0.6 16.6± 0.5* 18.3± 0.8 17.6± 0.6
Notes.
*p< 0.05 as compared to group A. Data are expressed in mean SEM; (n= 7 in group A and n= 8 in groups B, C and D).
Effect of treatment on food intake, on body weight gain and energy
expenditure
Cumulative food intake after 34 days of treatment was reduced in group B (100 mg kg−1)
compared to the other groups (Table 2). Moreover, a decline (p= 0.018) in cumulative
bodyweight change was observed for the same group compared to the control group
(Table 2). This reduction in body weight in group B, could be explained by a decrease
(p= 0.011) in fat mass without any changes in lean mass (Table 2). Energy expenditure was
measured for 24 h after 35 days of treatment. There were no significant effects of treatment
on expenditure per animal or relative to body weight over the whole 24 h or during the
light or dark phases (data not shown).
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Figure 5 Plasma levels of ‘anti- and pro- inflammatory’ cytokines after chronic treatment with
low dose of sage MetOH extract. Comparison between the levels of anti-inflammatory (A), and pro-
inflammatory cytokines (B), measured in plasma samples collected from fed mice treated for five weeks
with sage extract low dose sage MetOH extract (100 mg/kg/day), and mice control group (water: 10
ml/kg/day). Values represent mean± SEM (n = 7 in group A and n = 8 in group B) , and statistical
significance compared with the vehicle group data is shown as: ∗P < 0.05 and ∗∗P < 0.01.
Full-size DOI: 10.7717/peerj.4166/fig-5
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Figure 6 Sage fatty acids profile analysed by Gas Chromatography (GC). Typical chromatogram of sage
fatty acid profile analyzed by GC. The composition of fatty acid in sage MetOH extract contains different
classes ranging from C4:0 to C24:0. FA methyl esters (FAMEs) were identified by comparing each sample
with a standard FAME reference mixture, and FA acid peak areas were calculated using HP ChemStation
software.
Full-size DOI: 10.7717/peerj.4166/fig-6
Pro- and anti-inflammatory cytokines
To investigate a potential anti-inflammatory effect of sage, plasma levels of a panel of
pro- and anti-inflammatory cytokines were measured. Compared to the control group,
there was an increase in the anti-inflammatory cytokines IL2, IL-4 and L-10 (p= 0.003,
p= 0.036 and p= 0.006; respectively) (Fig. 5A), and a decrease in pro-inflammatory
cytokines TNF-α, KC/GRO and IL-12 (p= 0.030, p= 0.004 and p= 0.034; respectively),
moreover the sage extract tend to reduce as well the plasma levels of IL-1β (Fig. 5B).
Fatty acids composition of Sage MetOH extract
As displayed in Fig. 6, the sage MetOH extract chromatographic analysis allowed the
identification of different FAs classes. The main FAs identified were: γ-linolenic acid
(30.51%), palmitic acid (24.31%), linoleic acid (10.41%), palmitoleic acid (7.99%),
eicosadienoic acid (4.01%), oleic acid (4.34%) and α-linolenic acid (3.49%) (Table 3).
DISCUSSION
Anti-diabetic properties of sage have been shown in in vitro as well as in in vivo studies.
However, all previous studies using diabetic animal models have been performed
in streptozotocin or alloxan mice or rats (Alarcon-Aguilar et al., 2002; Eidi, Eidi &
Zamanizadeh, 2005; Eidi & Eidi, 2009). Both streptozotocin and alloxan induce β-cell
death through alkylation of DNA by the nitrosourea moiety of these compounds. For
this reason, the previous animal models of diabetes are more representative of type 1
diabetes (T1D) than type 2 diabetes (T2D). Type 2 diabetes is more common in older
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Table 3 Fatty acids (FAs) composition of sage Methanol extract, measured by Gas Chromatography (GC). FAs were analysed by GC in the fol-
lowing conditions: injector and Flame Ionization Detector (FID) temperature were set at 250 ◦C and 280 ◦C, respectively. Oven temperature was
kept at 15 ◦C for 1 min then gradually raised to 230 ◦C at 10 ◦C/min and subsequently, held isothermal for 10 min. Nitrogen was the carrier gas at a
split ratio of 1:50, a linear velocity of 38.5 cm/s and a flow rate of 1.2 ml/min.
Nomenclature Name Content (µg/g) Percentage%
; C4:0 Butyric acid 27.99 0.98
; C6:0 Caproic acid 28.11 0.99
; C10:0 Citric acid 26.94 0.95
; C12:0 Lauric acid 35.14 1.23
; C14:0 Myristic acid 44.27 1.55
; C16:0 Palmitic acid 692.34 24.32
; C18:0 Stearic acid 127.67 4.48
; C20:0 Arachidic acid 71.30 2.50
;
Saturated fatty acids
(SFAs)
C24:0 Lignoceric acid 32.40 1.14
; C16:1 ω-7 Palmitoleic acid 227.71 8.00
; C18:1 ω-9 Oleic acid 123.70 4.34
; C18:1 ω-7 Vaccenic Acid 22.89 0.80
; C20:1 ω-9 Gadoleic acid 7.36 0.26
; C22 1 ω-9 Erucic acid 0.2 0.01
;
Monounsaturated
fatty acids (MUFAs)
C24:1 ω-9 Nervonic acid 0.12 <0.01
; C18:2 ω-6 Linoleic acid 296.40 10.41
; C18:3 ω-6 γ-linolenic acid 868.69 30.51
; C18:3 ω-3 α-linolenic acid 99.48 3.49
;
Polyunsaturated
fatty acids (PUFAs)
C20:2 ω-6 Eicosadienoic acid 114.29 4.01
male population and associated with persistent low grade inflammation related to adipose
tissue expansion (Griffin et al., 2016; Pirola & Candido Ferraz, 2017). Hence, HFD-induced
obesity in 15 to 16 weeks old male mice presents an excellent model of the pre-T2D state,
since the prevalence of T2D is greatly increased in obesity. The present study investigated
the effect of sage extract on lipolysis and lipogenesis in murine pre-adipocytes (3T3-L1), as
well as the protective properties of low and high doses of the plant extract on inflammation,
obesity and insulin resistance in a HFD animal model.
Our finding in vitro revealed that sageMetOH extract has no effect on lipolytic activity in
3T3-L1 cells; however sage-treated animals had a decrease in plasmaNEFA and triglycerides
levels, suggesting an inhibition of lipolysis. This may be because 3T3-L1 cells differ from
primary adipocytes, or because in vivo there are influences of sage on other tissues that
indirectly lower plasma NEFA or triglyceride levels. In sage treated mice, the plant extract
improves insulin sensitivity, this improvement may be partly due to a direct effect on
adipose tissue and thereby it may enhances the anti-lipolytic effect of insulin, resulting in
a decrease in plasma NEFA levels. Furthermore, lipolysis in adipose tissue is modulated
in vivo by various factors such as insulin, glucagon, epinephrine, norepinephrine, ghrelin,
growth hormone, testosterone, and cortisol, which is not the case in vitro.
In addition, the plant extract reduced lipid droplets accumulation in a concentration-
response manner when the cells were treated during both the differentiation and nutrition
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steps. Obesity is a pathological disorder characterized by excessive fat storage endogenously;
and here we demonstrate that sage MetOH extract exhibited significant in vitro inhibition
of lipid droplets accumulation in mature adipocytes. However, sage extract was more
efficient on reducing lipid storage when it was added to both differentiation and nutrition
media (Fig. 1D) instead to differentiation or nutrition medium alone (Figs. 1B and 1C).
Further analysis of the upregulation or downregulation of genes such as CCAAT/enhancer
binding protein-α (C/EBP-α) and peroxisome proliferator-activated receptor gamma
(PPAR-γ), involved in the differentiation of pre-adipocytes into fully mature adipocytes,
will indicate which mechanisms sage employs in decreasing lipogenesis.
The efficacy of S. officinalis in the prevention of lipid accumulation within 3T3-L1
adipocytes is consistent with it reducing bodyweight gain (related to adipose tissue
hypertrophy) in HFD mice treated with low dose sage MetOH extract. Nevertheless,
this anti-obesity effect of sage might be due also to reduced food intake (Table 2).
In HFD animals, the treatment with low dose MetOH extract for two weeks, resulted
in an improvement of glucose tolerance, and a reduction of plasma insulin levels in
response to glucose load. After three weeks of treatment, the HOMA-IR index reflecting
insulin resistance was significantly decreased in sage treated-animal. The results confirm
an improvement in tissue insulin sensitivity. This result is in contrast with those of Eidi &
Eidi (2009), who reported that after two weeks sage ethanol extract significantly decreased
serum glucose, whereas it increased serum insulin levels in treated induced diabetic rats
by STZ as compared with control diabetic rats, and those of Alarcon-Aguilar et al. (2002)
who demonstrated that the water ethanol extract of sage showed hypoglycemic activity in
both normo-glycemic and in mildly alloxan-diabetic mice, but required the presence of
insulin to exhibit its activity. On the other hand, Eidi, Eidi & Zamanizadeh (2005) reported
same results as our study, showing that intraperitoneal administration sage MetOH
extract significantly decreased blood glucose in fasted STZ-diabetic rats without increasing
insulin release.
Our evidence from blood glucose and plasma insulin levels that low dose sage improved
insulin sensitivity was confirmed by an insulin tolerance test conducted after four weeks
of treatment. Thus, mice treated with sage low dose exhibited a significant decrease in
blood glucose levels in response to intraperitoneal insulin injection. This test, to the best
of our knowledge, was performed on sage-treated mice for the first time and confirms an
insulin-sensitizer effect of sage extract. Moreover the chronic treatment with low sage dose
resulted in a significant decrease in fed plasma insulin levels. A similar effect was observed
in the rosiglitazone-treated mice.
Sage, at low dose (100 mg kg−1/day), has shown a better beneficial effects on glucose
tolerance, insulin sensitivity, bodyweight gain and food intake, when compared with high
dose (400 mg kg−1/day). This might be explained by an increased daily intake in palmitic
acid (PA). According to the content in PA of sage MetOH extract (Table 3), the daily
intake of PA, in high dose sage treated mice was 277 µg kg −1, compared to 69.2 µg kg−1
in low dose treated group. High levels of PA lead to insulin resistance (Reynoso, Salgado &
Calderón, 2003).
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Indeed, saturated fatty acids aremajor contributors to this process, as they directly impair
insulin sensitivity in adipocytes and muscle cells in culture through pro-inflammatory
effect-induced insulin resistance (Bilan et al., 2009). Moreover, in human study, Stevenson,
Clevenger & Cooper (2015) have reported that PUFAs (Bilan et al., 2009) rich diet
consumption resulted in a decrease in ghrelin and an increase in peptide YY plasma
levels, when compared to SFAs rich diet. This might explain the beneficial effect on food
intake of sage low dosewhen compared to high dose. Nevertheless, it is reasonable to explain
the absence of the beneficial effects of high dose by a possible presence of compounds that
could be toxic at high levels. However, Eidi, Eidi & Zamanizadeh (2005) have used higher
dose (500 mg/kg/day) and no toxic effect has been observed. Moreover, Alves Rodrigues et
al. (2012), have investigated in mice the toxicological effects of the hydroalcoholic extract
from Salvia officinalis leaves. In the acute toxicity test, the LD50 value was close to 45 g/kg,
which is over than 110 fold when compared to the high dose (400 mg/kg/day) used in our
study. The HPLC profile (Table 4) of sage methanol extract showed that sage contains
13 compounds with almost no presence of toxic compounds. We have also conducted a
preliminary study on dose–response of methanol sage extract on 3T3-L1 cell proliferation
and cell viability (using methylene blue assay), no toxic effect has been observed.
This finding suggests that sage MetOH extract might act more efficiently at low doses,
on bodyweight gain and insulin resistance. Further studies using lower doses at 50, 25 and
10 mg kg−1 are needed to select the most effective dose. Adding palmitic acid to the dose
extract should also be taking into consideration to see whether it prevents the beneficial
effect.
Alves Rodrigues et al. (2012), showed that oral administration of the hydroalcoholic
extract and active compounds isolated from sage, such as carnosol, oleanolic and ursolic
acids reduced the nociception and oedema induced by different chemical stimuli. A study
showed that S. officinalis may be used just as an adjuvant in anti-inflammatory therapy
(Oniga et al., 2007). Anti-inflammatory activity of sage essential oil assessed in vitro showed
that it significantly inhibited nitric oxide production elicited by LPS in macrophages (Abu-
Darwish et al., 2013). Our study evaluated, for the first time, sage MetOH leaf extract effect
on plasma inflammatory cytokines in HFD animals. Sage increased significantly the plasma
levels of anti-inflammatory cytokines (IL-2, IL-4 and IL-10) and exhibited an opposite
effect on pro-inflammatory cytokines by decreasing the plasma levels of TNF-α, KC/GRO
and IL-12. KC/GRO is highly induced by pro-inflammatory cytokines such as TNF-α
(Son et al., 2007) and the fact that plasma levels of TNF-α were decreased (p= 0.030)
suggests that sage extract modulates cytokines gene expression by down regulating TNF-α
expression and indirectly inhibiting KC/GRO release. The beneficial ant-inflammatory
effects of sage methanol extract might be related to the high levels of phenolic compounds
(Table 4), particularly in Rosmarinic acid (Jin et al., 2017). Nevertheless, a study on the
expression of IL-10, IL-4, TNF-α and KC/GRO in white adipose tissue is needed to confirm
the mechanism of action.
PUFAs prevent diet-induced insulin resistance in rodents (Storlien et al., 1987). Indeed,
various FAs serve as natural ligands for the three subtypes of PPARs: α, γ and δ (Christensen
et al., 2009). PPAR α and γ agonists modulate important metabolic events and they are the
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Table 4 Phenolic compounds content of S. officinalismethanol extract. The phenolic compounds sep-
aration was performed using a Hewlett-Packard liquid chromatographic system. The identification and
quantification of compounds was carried out by comparison of their retention times and pics area, with
respect to pure standards analyzed under the same operating conditions. Values are given as mean± stan-
dard error of three replicate analyses.
Phenolic compounds RTa (min) Content (mg/Kg of DW)b
; Phenolic acid
;1 Gallic acid 5.029 11.08± 1.2
;2 4-OH Benzoic acid 7.559 9.95± 1.3
;3 Rosmarinic acid 12.458 290.73± 8.4
;4 Cinnamic acid 17.138 17.13± 2.6
; Flavones
;5 Luteolin-7-O-glucoside 9.230 10.89± 1.7
;6 Apigenin-7-O-glucoside 10.616 10.80± 1.8
;7 Apigenin 16.700 18.50± 2.2
; Flavonols
;8 Rutin 8.429 10.15± 1.5
;9 Quercetin 15.101 2.26± 0.4
; Stilbenes
;10 Resveratrol 15.411 7.15± 1.2
; Catechins
;11 Catechin Hydrate 6.278 6.75± 0.9
; Phenylethanoid glycoside
;12 Verbascoside 8.806 17.47± 1.6
; Lignans
;13 Pinoresinol 15.782 1.84± 0.3
Notes.
aRetention time.
bDry weight.
targets of drugs or candidate drugs that are effective in the treatment of metabolic disorders
such as T2D, atherosclerosis (Berger, Akiyama & Meinke, 2005) and obesity (Bassaganya-
Riera, Guri & Hontecillas, 2011). Natural PPARs have fewer adverse effects than novel
synthetic PPARs ligands that are suspected to promote carcinogenesis in rodents by as
yet, unknown mechanisms (Berger, Akiyama & Meinke, 2005). Nevertheless, other studies
have reported an antitumor effects of the PPAR-γ agonists thiazolidinediones (TZDs), in
vivo (Chaffer et al., 2006), as well as in vitro (Xu et al., 2003). These anti-proliferative effects
of TZDs, including cell cycle arrest and/or increased apoptosis, are PPAR-γ-pathways
dependent in some cancer cell types, while in other tumor cells, they occur independently.
GC analysis showed that sage MetOH extract had a high content in PUFAs (48.4%),
particularly in γ-linolenic acid, linoleic acid, and α-linolenic acid. PPAR-γ is effectively
activated by PUFAs, such as linolenic acid (Dubuquoy et al., 2002). Indeed, γ-linolenic and
α-linolenic acids alone account for 34% of sage FAs content in MetOH extract, and both
of them are PPAR-α and γ agonists (Christensen et al., 2010; Xu et al., 1999). Furthermore,
several studies reported that the PUFA linoleic acid can function as ligands for both PPAR-α
and PPAR-γ (Kliewer et al., 1997).
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Our finding revealed the presence of both PPAR α and γ agonists in MetOH sage extract
and support previous studies which demonstrated that dichloromethane (DCM) and
Ethanol (EtOH) sage extracts contains PPARs agonists such as α-linolenic acid, γ-linolenic
acid, carnosic acid, oleanolic acid, ursolic acid and carnasol (Christensen et al., 2010; Lim
et al., 2007; Rau et al., 2006).
CONCLUSION
Sage MetOH extract shows an anti-adipogenic effect by in vitro inhibition of lipid
droplets accumulation in adipocytes. In a nutritional model obesity associated with
insulin resistance, sage MetOH extract reduces bodyweight gain by a decrease in total fat
mass and exhibits anti-diabetic properties by an improvement of glucose tolerance and
insulin sensitivity. Sage MetOH extract moderately improves lipid profile, also reduces
the plasma levels of the pro-inflammatory cytokines TNF-α, KC/GRO and IL-12 and
increases the anti-inflammatory cytokines IL-2, IL-4 and IL-10. Our results suggest that
decreased adipose tissue associated with improved insulin sensitivity and modulation of
inflammatory cytokines release, balance the abnormal glucose metabolism observed in a
pre-diabetic state.
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